U.S. Colorectal Cancer Screening Market 规模与份额分析 - 成长趋势与预测 (2024 - 2031)
U.S. Colorectal Cancer Screening Market is Segmented By Test Type (Fecal Immunochemical Test (FIT), Guaiac-based Fecal Occult Blood Test, Stool DNA Test, and Others), By Imaging Type (Sigmoidoscopy, Colonoscopy, Virtual Colonoscopy, and Others), By End User (Hospitals, Diagnostic Laboratories, Academic and Research Institutes, and Others). The report offers the value (in USD billion) for the above-mentioned segments.
Competitive overview of U.S. Colorectal Cancer Screening Market
在美国色谱癌筛查市场运营的主要玩家包括Polymedco公司、Eiken化学有限公司、Sysmex公司、Quidel公司、Novigenix SA、Hemosure公司、精密科学公司、Epigenomics公司、Olympus公司、临床基因组技术有限公司、Abbott、F.Hoffmann-La Roche有限公司、Siemens保健公司、Koninklijke Philips N.V.、Thermo Fisher科学公司、Illumina公司、Myriad遗传公司、QIAGEN、Merck KGaA
U.S. Colorectal Cancer Screening Market Leaders
- Polymedco Inc. (英语).
- 艾肯化工有限公司.
- Sysmex公司
- 奎德尔公司
- 诺维格尼克斯
*Disclaimer: Major players are listed in no particular order.
U.S. Colorectal Cancer Screening Market - Competitive Rivalry, 2023
U.S. Colorectal Cancer Screening Market
Market Consolidated
(Dominated by major players)
(Dominated by major players)
Market Fragmented
(Highly competitive with lots of players.)
(Highly competitive with lots of players.)
*Source: Coherent Market Insights